ASM Clinical Microbiology Issues Update Invite - BSI

Appendix L2

ASM Clinical Microbiology Issues Update
Month, Year
Volume XX, Number
To read this newsletter on-line, go to:

PSAB ACTIVITIES


ASM Applauds FY 2015 Budget’s Increased Funding to Fight Antibiotic
Resistance



ASM Endorses American Cures Act of 2015



ASM and PASCV Issue Joint Statement on FDA’s LDT



ASM Participates in CDC Telebriefing on the Ebola Outbreak in West Africa



ASM Attends December CCCLW Meeting



ASM Signs Implementation Letter on Combatting Antimicrobial Resistance



ASM attends FDA Anti-Infective Drugs Advisory Committee Meeting



ASM Meets with Officials from WRAIR



Minority Microbiology Mentor Newsletter

ASM NEWS, JOURNAL ARTICLES AND UPDATES


Bloodstream Infections Laboratory Practice Survey



December Clinical Microbiology Portal Hot Topic



Clinical Microbiology Portal Q & A



ASM Conferences



ASM Journal Articles of Interest



ASM Press



Articles of Interest

FEDERAL AGENCY UPDATES


FDA Grants First CLIA Waiver for Nucleic Acid-Based Flu Diagnostic Test



Emergency Use Authorizations of In Vitro Diagnostic Devices for Detection of
Ebola Zaire Virus



Optimizing FDA’s Regulatory Oversight of Next Generation Sequencing
Diagnostic Tests



FDA Approves a Second Vaccine to Prevent serogroup B Meningococcal
Disease



FDA Approves New Antibacterial Drug Zerbaxa



FDA Approves Pathogen Reduction System to Treat Platelets



FDA Approves First Pathogen Reduction System to Treat Plasma



FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening Test
for Syphilis



MMWR Articles of Interest

OTHER INFORMATION AND UPDATES


Articles of Interest

ASM NEWS, JOURNAL ARTICLES AND UPDATES

Bloodstream Infections Laboratory Practice Survey
The American Society for Microbiology (ASM) and the Centers for Disease Control

and Prevention (CDC) are conducting a survey to learn about laboratories’ current
practices related to the effectiveness of rapid diagnostic tests to promote more
accurate and timely administration of targeted antibiotic therapy for patients with
bloodstream infections with the goal of improving practice and patient care. This
survey will take approximately 20 minutes to complete; participation is voluntary. The
results from the survey will be compiled and shared in aggregate as a learning tool,
presented at professional conferences and potentially published in a professional
journal in the field of laboratory science. All information collected in this survey will be
kept in a secure manner; your IP address will NOT be retained.
If your laboratory has not yet participated in the survey, please visit
https://www.surveymonkey.com/s/2CZ9HJQ and complete it by (date to be
determined by OMB approval). Your feedback is critical to guiding ASM and CDC in
their efforts to improve practice and patient care. Contact clinmicro@asmusa.org with
questions or concerns.

American Society For Microbiology © 2015